Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia

Author:                

Publisher: Spandidos Publications

E-ISSN: 1791-2423|47|1|81-90

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.47, Iss.1, 2015-01, pp. : 81-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract